시장보고서
상품코드
1623692

안검성형술 시장 규모, 점유율, 성장 분석 : 유형별, 기술별, 성, 성별, 서비스 제공업체별, 지역별 - 산업 예측(2025-2032년)

Blepharoplasty Market Size, Share, Growth Analysis, By Type, By Technology, By Gender, By Service Provider, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 165 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안검성형술 시장 규모는 2023년 37억 1,000만 달러로 평가되며, 2024년 39억 9,000만 달러에서 2032년 77억 5,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 7.6%의 CAGR로 성장할 것으로 예상됩니다.

안검성형술 시장은 65세 이상 노인 인구의 증가로 인해 최소침습적 미용 성형에 대한 수요가 증가하면서 강력한 성장세를 보이고 있습니다. 노화로 인해 눈꺼풀에 주름이 생기고 피부가 처지면서 미용적, 기능적 측면을 개선하기 위해 안검성형술을 찾는 사람들이 늘고 있습니다. 이 수술은 눈꺼풀 처짐, 과도한 지방 축적과 같은 문제를 효과적으로 해결하고 눈의 붓기를 크게 줄이고 시력을 개선하는 데 도움이 됩니다. 이러한 눈꺼풀 질환의 유병률이 증가함에 따라 안검성형술에 대한 시장 수요도 증가하고 있으며, 노년층의 외모와 삶의 질 향상에 대한 열망으로 인해 분석 기간 동안 이 분야가 강력한 성장 궤도를 그릴 것임을 보여줍니다.

목차

소개

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 가정과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porters 분석

주요 시장 인사이트

  • 핵심성공요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 규제 상황
  • 고객과 구매 기준 분석

안검성형술 시장 규모 : 유형별

  • 시장 개요
  • 위눈꺼풀 안검성형술
  • 아래눈꺼풀 안검성형술
  • 복합 쌍꺼풀 수술
  • 기타

안검성형술 시장 규모 : 기술별

  • 시장 개요
  • ARC 테크놀러지
  • 파이버 블라스팅 플라즈마 기술

안검성형술 시장 규모 : 성별

  • 시장 개요
  • 여성
  • 남성

안검성형술 시장 규모 : 서비스 프로바이더별

  • 시장 개요
  • 병원
  • 클리닉
  • 외래 진료

안검성형술 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채용한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출 전년비 비교(2022-2024)

주요 기업 개요

  • AbbVie Inc.(USA)
  • Cutera Inc.(USA)
  • Cynosure Inc.(USA)
  • Erchonia Corporation(USA)
  • Hologic Inc.(USA)
  • Lumenis Ltd.(Israel)
  • Merz Pharma GmbH & Co. KGaA(Germany)
  • Sciton Inc.(USA)
  • Alma Lasers Ltd.(Israel)
  • Bausch Health Companies Inc.(Canada)
  • El.En. S.p.A.(Italy)
  • Fotona d.o.o.(Slovenia)
  • InMode Ltd.(Israel)
  • Lutronic Corporation(South Korea)
  • Solta Medical Inc.(USA)
  • Valeant Pharmaceuticals International Inc.(Canada)
  • Sisram Medical Ltd.(Hong Kong)
  • Medtronic plc(Ireland)
  • LightScalpel Inc.(USA)
  • Grand Aespio Inc.(South Korea)

결론과 추천사항

ksm 25.01.21

Blepharoplasty Market size was valued at USD 3.71 Billion in 2023 and is poised to grow from USD 3.99 Billion in 2024 to USD 7.75 Billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The blepharoplasty market is experiencing robust growth due to the rising population aged 65 and older, fostering a heightened demand for minimally invasive cosmetic procedures. As aging leads to wrinkles and sagging skin around the eyelids, individuals increasingly seek blepharoplasty to enhance both the aesthetic and functional aspects of their eyes. This surgical intervention effectively addresses issues such as drooping eyelids and excess fatty deposits, significantly reducing eye puffiness and improving vision. As the prevalence of these eyelid conditions rises, so does the market demand for blepharoplasty, indicating a strong trajectory for growth in this segment throughout the analysis period, driven by the desire for improved appearance and quality of life among older adults.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blepharoplasty market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blepharoplasty Market Segmental Analysis

Global Blepharoplasty Market is segmented by type, technology, gender, service provider and region. Based on type, the market is segmented into upper eyelid blepharoplasty, lower eyelid blepharoplasty, combination eyelid surgery and others. Based on technology, the market is segmented into ARC technology and fibro blasting plasma technology. Based on gender, the market is segmented into female and male. Based on service provider, the market is segmented into hospitals, clinics and ambulatory. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Blepharoplasty Market

The blepharoplasty market is poised for significant growth due to various key drivers. High technological advancements in blepharoplasty techniques are expected to enhance market dynamics, particularly as the aging population faces a rise in eye-related issues like droopy eyelids and visual impairments. These trends are increasing the demand for blepharoplasty procedures. Furthermore, there is a growing consumer inclination towards improved aesthetics, which contributes to market expansion. Non-surgical methods, favored for their minimal invasiveness compared to traditional surgeries that require lengthy recovery and anesthesia, are becoming more prevalent. Innovative technologies such as plasma exercises provide cost-effective, instant results, presenting favorable prospects for the market's growth during the forecast period.

Restraints in the Blepharoplasty Market

One significant factor hindering the growth of the blepharoplasty market is the elevated costs associated with the procedure. The financial burden of undergoing blepharoplasty, coupled with potential complications such as dry eyes, muscle damage, and scarring, presents considerable challenges for both patients and healthcare providers. These elements contribute to hesitancy among prospective patients, effectively slowing the overall expansion of the market throughout the analysis period. As individuals weigh the benefits against the costs and risks involved, this restraint may lead to decreased demand, thereby impacting the overall dynamics of the blepharoplasty market.

Market Trends of the Blepharoplasty Market

The blepharoplasty market is experiencing a notable upward trend, driven by a growing societal focus on aesthetic enhancement and greater acceptance of cosmetic procedures. Increasingly, millennials are seeking eyelid surgery as part of a broader pursuit of self-improvement, bolstered by higher disposable incomes and shifting beauty standards. Additionally, advancements in surgical techniques and minimally invasive options have made blepharoplasty more accessible and appealing. The rise in health and wellness spending further supports this trend, as individuals prioritize their appearance and long-term well-being, positioning blepharoplasty as a pivotal segment within the expanding cosmetic surgery market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Global Blepharoplasty Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Upper Eyelid Blepharoplasty
  • Lower Eyelid Blepharoplasty
  • Combination Eyelid Surgery
  • Others

Global Blepharoplasty Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • ARC Technology
  • Fibro Blasting Plasma Technology

Global Blepharoplasty Market Size by Gender & CAGR (2025-2032)

  • Market Overview
  • Female
  • Male

Global Blepharoplasty Market Size by Service Provider & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Ambulatory

Global Blepharoplasty Market Size & CAGR (2025-2032)

  • North America (Type, Technology, Gender, Service Provider)
    • US
    • Canada
  • Europe (Type, Technology, Gender, Service Provider)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Technology, Gender, Service Provider)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Technology, Gender, Service Provider)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Technology, Gender, Service Provider)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • AbbVie Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cutera Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cynosure Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Erchonia Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lumenis Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Pharma GmbH & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sciton Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alma Lasers Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch Health Companies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • El.En. S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fotona d.o.o. (Slovenia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InMode Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lutronic Corporation (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solta Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Valeant Pharmaceuticals International Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sisram Medical Ltd. (Hong Kong)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LightScalpel Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grand Aespio Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제